Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Central Sensitization in Women With Adenomyosis: Prevalence, Risk Factors, and Treatment Failure

NCT07455721 is registered in ClinicalTrials.gov with IRCCS Azienda Ospedaliero-Universitaria di Bologna as lead sponsor.

NCT NCT07455721
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07455721 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Central Sensitization in Women With Adenomyosis: Prevalence, Risk Factors, and Treatment Failure
Lead sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phase
Observational
Overall status
Active, not recruiting
Start date
December 9, 2025
Completion date
June 30, 2028
Enrollment
1,200 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

adenomyosis